Sign In
Sign Up
Two Blokes
Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Lags Revenue Estimates
click to rate
Posted by
Two Blokes
May 16
- Filed in
Stock
- 2 views
Vivos Therapeutics, Inc. (VVOS) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to loss of $1.63 per share a year ago.
